original ) (raw )The primary and secondary antibody response to Escherichia coli O6 lipopolysaccharide analysed at the humoral and cellular level: Amount and avidity of the antibodies in relation to protective capacity
Staffan Ahlstedt
Immunology, 1973
View PDFchevron_right
Induction of bacteremia in newborn rats by Escherichia coli K1 is correlated with only certain O (lipopolysaccharide) antigen types
Gerd Pluschke
Infection and Immunity, 1983
View PDFchevron_right
Antibody Responses to Escherichia coli O157 and Other Lipopolysaccharides in Healthy Children and Adults
Ulises Hernandez
Clinical and Vaccine Immunology, 2003
View PDFchevron_right
Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice
Kok van Kessel
Infection and immunity, 1996
View PDFchevron_right
HUMORAL AND CELLULAR IMMUNE RESPONSE INDUCED BY E. Coli [O157:H7 AND O157:H7:K99] VACCINES IN MICE
Prof. Dr. Afaf abdulrahman Yousif
View PDFchevron_right
The primary and secondary antibody response to Escherichia coli 06 Lipopolysaccharide analysed at the humoral and cellular level
Staffan Ahlstedt
Immunology
View PDFchevron_right
Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccines
Joseph Shiloach
Infection and immunity, 1994
View PDFchevron_right
Safety and Immunogenicity of Escherichia coli O157 O‐Specific Polysaccharide Conjugate Vaccine in 2–5‐Year‐Old Children
Amina Ahmed
Journal of Infectious Diseases, 2006
View PDFchevron_right
Immunity and Protection Elicited by a Recombinant Vaccine Against Enterotoxigenic E. Coli
Eddy Bover
Biotecnologia …, 1995
View PDFchevron_right
The effects of Escherichia coli 0157: H7 lipopolysaccharide(LPS) from human, cattle and poultry isolates on haematological parameters of neonatal albino rats
Bassey Etim
European Journal of Experimental Biology, 2014
View PDFchevron_right
The effect of antibodies to the enterobacterial common antigen (ECA) on experimental mouse salmonellosis
Harri Saxén
FEMS Microbiology Letters, 1985
View PDFchevron_right
Antibodies to O-antigen of lipopolysaccharide are protective against neonatal infection with Escherichia coli K1
Gerd Pluschke
Infection and Immunity, 1985
View PDFchevron_right
Murine Monoclonal Antibodies Specific for Lipopolysaccharide of Escherichia coli O26 and O111
Jim Keen
Applied and Environmental Microbiology, 2000
View PDFchevron_right
Human IgG but not IgM Antibodies can Protect Mice from the Challenge with Live O6 Escherichia coli
Silvia Massironi
Scandinavian Journal of Immunology, 2005
View PDFchevron_right
Pathogenesis and Vaccines against Enterotoxigenic Escherichia Coli
mubabol journal
Journal of Babol University of Medical Sciences, 2017
View PDFchevron_right
Monoclonal antibodies reactive with K1-encapsulated Escherichia coli lipopolysaccharide are opsonic and protect mice against lethal challenge
Alan Cross
Infection and Immunity, 1986
View PDFchevron_right
Protective capacity of antibodies against Escherichia coli and K antigens
Staffan Ahlstedt
Infection and immunity, 1977
View PDFchevron_right
Disease management by vaccination using Escherichia coli antigens
Pallvarnanathasamy Dhasarathan
African Journal of Pharmacy and Pharmacology, 2010
View PDFchevron_right
Subcutaneous and intranasal immunization with type III secreted proteins can prevent colonization and shedding of Escherichia coli O157:H7 in mice
Dragan Rogan
Microbial Pathogenesis, 2008
View PDFchevron_right
Development of safe, effective and immunogenic vaccine candidate for diarrheagenic Escherichia coli main pathotypes in a mouse model
Asmaa Gohar
BMC Research Notes, 2016
View PDFchevron_right
Introductory evaluation of an oral, killed whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Egyptian infants
Remon Youssef
Pediatric Infectious Disease Journal, 2002
View PDFchevron_right
Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo
P. Michetti
Infection and Immunity, 1993
View PDFchevron_right
Alteration of the antibody response to escherichia coli o antigen in mice by prior exposure to various somatic antigens
Staffan Ahlstedt
Immunology, 1975
View PDFchevron_right
Pre-clinical in vitro and in vivo characterization of a maternal vaccination before conception to protect against severe neonatal infections caused byEscherichia coli K1
Youssouf Sereme
bioRxiv (Cold Spring Harbor Laboratory), 2022
View PDFchevron_right